Variant report
Variant | nsv971498 |
---|---|
Chromosome Location | chr7:126497328-126519764 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr7:126509086-126509186 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr7:126516526-126516933 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr7:126513084-126513338 | HepG2 | liver: | n/a | chr7:126513180-126513191 |
4 | CEBPB | chr7:126512782-126513296 | A549 | lung: | n/a | chr7:126513180-126513191 chr7:126513051-126513062 |
5 | CTCF | chr7:126516058-126516103 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr7:126497200-126497350 | GM12872 | blood: | n/a | n/a |
7 | CTCF | chr7:126518393-126518468 | Lung_OC | lung: | n/a | n/a |
8 | E2F4 | chr7:126497669-126497864 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | EP300 | chr7:126516665-126516869 | Hela-S3 | cervix: | n/a | chr7:126516804-126516813 |
10 | FAM48A | chr7:126503051-126503198 | GM12878 | blood: | n/a | n/a |
11 | GATA2 | chr7:126518124-126518572 | K562 | blood: | n/a | n/a |
12 | GATA2 | chr7:126515721-126516156 | K562 | blood: | n/a | n/a |
13 | HEY1 | chr7:126518298-126518493 | K562 | blood: | n/a | n/a |
14 | MXI1 | chr7:126502517-126502633 | K562 | blood: | n/a | n/a |
15 | MYC | chr7:126502384-126502606 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | MYC | chr7:126513593-126513633 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | POLR2A | chr7:126500081-126500269 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr7:126518290-126518548 | PFSK-1 | brain: | n/a | n/a |
19 | POLR2A | chr7:126507271-126507506 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr7:126512523-126512693 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr7:126508141-126508405 | MCF-7 | breast: | n/a | n/a |
22 | RAD21 | chr7:126496180-126497369 | SK-N-SH | brain: | n/a | chr7:126496915-126496934 |
23 | RFX5 | chr7:126514266-126514453 | K562 | blood: | n/a | n/a |
24 | SIX5 | chr7:126518285-126518546 | K562 | blood: | n/a | n/a |
25 | STAT3 | chr7:126502916-126503070 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | USF1 | chr7:126518332-126518508 | HepG2 | liver: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF800-7 | chr7:126508821-126510586 | NONHSAT123122 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224981 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576945100 | chr7:126497468-126497469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181607855 | chr7:126497518-126497519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545901201 | chr7:126497530-126497531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561044179 | chr7:126497568-126497569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531760962 | chr7:126497605-126497606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575206465 | chr7:126497682-126497683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571925622 | chr7:126497683-126497684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532668759 | chr7:126497704-126497705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10225203 | chr7:126497762-126497763 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs143709095 | chr7:126497775-126497776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536829087 | chr7:126497810-126497811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555544852 | chr7:126497845-126497846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567345096 | chr7:126497875-126497876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537878711 | chr7:126497901-126497902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs151047466 | chr7:126497925-126497926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577889274 | chr7:126497947-126497948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544927786 | chr7:126497957-126497958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117353425 | chr7:126497967-126497968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140927398 | chr7:126497979-126497980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528175563 | chr7:126498024-126498025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542393576 | chr7:126498028-126498029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59643816 | chr7:126498041-126498042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561080843 | chr7:126498081-126498082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79418227 | chr7:126498086-126498087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370339616 | chr7:126498110-126498111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543823123 | chr7:126498114-126498115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184855139 | chr7:126498184-126498185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80254577 | chr7:126498211-126498212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2283080 | chr7:126498232-126498233 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs188549804 | chr7:126498261-126498262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181213054 | chr7:126498294-126498295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79310800 | chr7:126498345-126498346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2283081 | chr7:126498385-126498386 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs537514323 | chr7:126498391-126498392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533225927 | chr7:126498436-126498437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376716500 | chr7:126498455-126498456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74522953 | chr7:126498553-126498554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150185742 | chr7:126498559-126498560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139365197 | chr7:126498567-126498568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553679497 | chr7:126498573-126498574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141813810 | chr7:126498574-126498575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73228923 | chr7:126498619-126498620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535470511 | chr7:126498707-126498708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554317011 | chr7:126498737-126498738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185433410 | chr7:126498738-126498739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543514704 | chr7:126498748-126498749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565372820 | chr7:126498756-126498757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116166591 | chr7:126498803-126498804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147088667 | chr7:126498845-126498846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138473093 | chr7:126498881-126498882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
Attention deficit hyperactivity disorder | 22138692 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126496600-126497400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr7:126496600-126497400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr7:126496600-126497400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:126496800-126497400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr7:126496800-126498600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr7:126497000-126497400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr7:126497000-126497400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr7:126497000-126497400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr7:126497000-126497800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
10 | chr7:126497400-126498400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr7:126497400-126498600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
12 | chr7:126497400-126498600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
13 | chr7:126497400-126498600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr7:126498600-126498800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr7:126498600-126498800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr7:126498800-126499000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr7:126498800-126499000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr7:126498800-126499000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr7:126508200-126508400 | Enhancers | Pancreas | Pancrea |
20 | chr7:126513600-126513800 | Enhancers | Small Intestine | intestine |
21 | chr7:126516200-126517000 | Enhancers | Hela-S3 | cervix |
22 | chr7:126517000-126521400 | Weak transcription | Hela-S3 | cervix |